Genesis Drug Discovery & Development

Genesis Drug Discovery & Development (GD3) is a fully integrated CRO that provides services from target discovery to IND filing and management of Phase I-III clinical trials to support our clients' drug discovery programs. GD3's global portfolio includes HTS and analytical development, synthetic organic and medicinal chemistry, DMPK/in vivo pharmacology and safety pharmacology, toxicology, and clinical trial services for regulatory approval of new drugs and medical device products.